Patents by Inventor Stuart J. Updike
Stuart J. Updike has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20100099971Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.Type: ApplicationFiled: December 22, 2009Publication date: April 22, 2010Applicant: DexCom, Inc.Inventors: Mark C. Shults, Stuart J. Updike, Rathburn K. Rhodes
-
Publication number: 20080296155Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.Type: ApplicationFiled: May 1, 2008Publication date: December 4, 2008Applicant: DEXCOM, INC.Inventors: Mark C. Shults, Rathburn K. Rhodes, Stuart J. Updike, James H. Brauker
-
Publication number: 20080228051Abstract: An implantable analyte-measuring device including a membrane adapted to promote vascularization and/or interfere with barrier cell layer formation. The membrane includes any combination of materials, architecture, and bioactive agents that facilitate analyte transport to provide long-term in vivo performance of the implantable analyte-measuring device.Type: ApplicationFiled: February 26, 2008Publication date: September 18, 2008Applicant: DexCom. Inc.Inventors: Mark C. Shults, James H. Brauker, Victoria Carr-Brendel, Mark A. Tapsak, Dubravka Markovic, Stuart J. Updike, Rathbun K. Rhodes
-
Publication number: 20080228054Abstract: An implantable analyte-measuring device including a membrane adapted to promote vascularization and/or interfere with barrier cell layer formation. The membrane includes any combination of materials, architecture, and bioactive agents that facilitate analyte transport to provide long-term in vivo performance of the implantable analyte-measuring device.Type: ApplicationFiled: February 26, 2008Publication date: September 18, 2008Applicant: DexCom, Inc.Inventors: Mark C. Shults, James H. Brauker, Victoria Carr-Brendel, Mark A. Tapsak, Dubravka Markovic, Stuart J. Updike, Rathbun K. Rhodes
-
Publication number: 20080208025Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.Type: ApplicationFiled: May 1, 2008Publication date: August 28, 2008Applicant: DEXCOM, INC.Inventors: Mark C. Shults, Rathburn K. Rhodes, Stuart J. Updike, James H. Brauker
-
Patent number: 7136689Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that slows accurate date to be obtained over long periods of time.Type: GrantFiled: January 19, 2005Date of Patent: November 14, 2006Assignee: DexCom, Inc.Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
-
Patent number: 7110803Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.Type: GrantFiled: September 9, 2003Date of Patent: September 19, 2006Assignee: DexCom, Inc.Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
-
Patent number: 6862465Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.Type: GrantFiled: July 27, 2001Date of Patent: March 1, 2005Assignee: DexCom, Inc.Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
-
Patent number: 6741877Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.Type: GrantFiled: January 21, 2000Date of Patent: May 25, 2004Assignee: DexCom, Inc.Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
-
Publication number: 20040045879Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.Type: ApplicationFiled: September 9, 2003Publication date: March 11, 2004Applicant: DexCom, Inc.Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
-
Publication number: 20040011671Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.Type: ApplicationFiled: July 27, 2001Publication date: January 22, 2004Applicant: Dexcom, Inc.Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
-
Patent number: 6001067Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.Type: GrantFiled: March 4, 1997Date of Patent: December 14, 1999Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
-
Patent number: 4994167Abstract: A biological fluid measuring device for determining the presence and the amounts of substances in a biological fluid without the need for dilution of the fluid comprises a main housing including electronic circuit means and at least one electrode, and a cartridge having a membrane. The cartridge is removably mounted on the housing and the membrane is maintained operably associated by osmotic pressure with the electrode. The cartridge also includes means for protecting the membrane when the device is not in use. An enzyme electrode is also disclosed comprising a multilayered homogeneous monolithic membrane and an intermediate water-swellable coating.Type: GrantFiled: July 7, 1988Date of Patent: February 19, 1991Assignee: Markwell Medical Institute, Inc.Inventors: Mark G. Shults, Christopher C. Capelli, Stuart J. Updike
-
Patent number: 4757022Abstract: A biological fluid measuring device for determining the presence and the amounts of substances in a biological fluid without the need for dilution of the fluid comprises a main housing including electronic circuit means and at least one elecrode, and a cartridge having a membrane. The cartridge is removably mounted on the housing and the membrane is operably associated with the electrode. The cartridge also includes means for protecting the membrane when the device is not in use.Type: GrantFiled: November 19, 1987Date of Patent: July 12, 1988Assignee: Markwell Medical Institute, Inc.Inventors: Mark C. Shults, Christopher C. Capelli, Stuart J. Updike
-
Patent number: 4568335Abstract: A device comprising a container and a threaded rotatable plunger mechanism including means for controllably advancing the plunger through the container can administer a precise dose of a drug-containing fluid subcutaneously at regular intervals. The means for controllably advancing the plunger comprises a drive tube concentrically mounted about a threaded rod operating within the container, the drive tube having ramp means at the upper end thereof, a ratchet head including a resilient member in operative communication with the upper end of the drive tube and a rotatable knob adjacent the ratchet head whereby rotation of the knob in one direction rotates the drive tube and the threaded rod to deliver the fluid through an outlet of the container.Type: GrantFiled: September 7, 1982Date of Patent: February 4, 1986Assignee: Markwell Medical Institute, Inc.Inventors: Stuart J. Updike, Mark C. Shults
-
Patent number: 4240438Abstract: A method for monitoring blood glucose levels at frequent intervals, which includes a method for equalizing the temperature and oxygen level in the blood and sensing the rate of oxygen consumption by the glucose contained in the blood in the presence of glucose oxidase enzyme immobilized on a hydrophobic membrane covering a measurement electrode and elements employed therein including the equalizing method and the electrode and method for preparing same.Type: GrantFiled: October 2, 1978Date of Patent: December 23, 1980Assignee: Wisconsin Alumni Research FoundationInventors: Stuart J. Updike, Mark C. Shults
-
Patent number: 4138474Abstract: A method and device for immunological determinations wherein the device comprises a container housing a volume of dry, insoluble, yet highly hydrophilic, gel particles, containing binding protein or combinations of binding protein and radio-active tag material and in which the dry gel particles are characterized by pores of a size that permit entry of low molecular weight components into the intra gel volume but insufficient to permit entry of large molecular weight components which remain in the extra gel volume.Type: GrantFiled: May 1, 1973Date of Patent: February 6, 1979Assignee: Wisconsin Alumni Research FoundationInventor: Stuart J. Updike
-
Patent number: 3996141Abstract: A semi-permeable membrane containing a catalyst for conversion of hydrogen peroxide introduced from one side of the semi-permeable membrane to molecular oxygen which is released from the opposite side of the semi-permeable membrane. The catalyst is preferably in the form of a ruthenium oxide or sulfide and preferably in assymetrical distribution in the membrane.Type: GrantFiled: January 17, 1974Date of Patent: December 7, 1976Assignee: Wisconsin Alumni Research FoundationInventor: Stuart J. Updike
-
Patent number: 3970429Abstract: A method for immunological determinations in which use is made of a volume of a hydrophilic, insoluble, porous gel particles having binding proteins entrapped therein, and in which a fluid to be tested is introduced into the volume of gel particles whereby some of the binding sites are occupied followed by exposure of the gel particles to radio active tagged material followed by measurement of the radio activity of the unbound or bound tagged material. The binding proteins in the gel particles are returned to their original state for re-use by treatment with acidic medium to effect detachment of the bound material followed by washing to effect removal of the unbound material, and then drying.Type: GrantFiled: January 28, 1974Date of Patent: July 20, 1976Assignee: Wisconsin Alumni Research FoundationInventor: Stuart J. Updike
-
Patent number: 3953329Abstract: The removal of carbon dioxide from blood plasma by transport through a dialysis membrane in the form of bicarbonate ion, in which the electrolyte supplies hydroxyl ion for transport back through the membrane for maintaining normal blood pH.Type: GrantFiled: October 5, 1972Date of Patent: April 27, 1976Assignee: Wisconsin Alumni Research FoundationInventor: Stuart J. Updike